XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Grant revenue $ 0 $ 81,526
Operating expenses:    
Research and development 2,819,189 1,330,544
General and administrative 1,451,425 1,179,024
Total operating expenses 4,270,614 2,509,568
Loss from operations (4,270,614) (2,428,042)
Other income:    
Interest income 232,698 527
Net loss $ (4,037,916) $ (2,427,515)
Basic and diluted:    
Net loss per common share (in dollars per share) $ (0.15) $ (0.34)
Weighted average shares outstanding (in shares) 26,338,576 7,109,473